Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tadeusz Robak & Paweł Robak. (2023) Refractory and relapsed hairy-cell leukemia (HCL): casting light on promising experimental drugs in clinical trials. Expert Opinion on Investigational Drugs 32:4, pages 311-324.
Read now
Read now
Constantin A. Dasanu, Juliana Alvarez-Argote & Catherine B Goff. (2022) Selecting appropriate therapy for hairy cell leukemia: current state and future prospects based on molecularly defined characterization. Expert Opinion on Pharmacotherapy 23:11, pages 1239-1241.
Read now
Read now
Qiuying Liu, Nicholas Harris, Narendranath Epperla & Leslie A Andritsos. (2021) Current and Emerging Therapeutic Options for Hairy Cell Leukemia Variant. OncoTargets and Therapy 14, pages 1797-1805.
Read now
Read now
Robert J. Kreitman. (2019) Hairy cell leukemia: present and future directions. Leukemia & Lymphoma 60:12, pages 2869-2879.
Read now
Read now
Agnieszka Janus & Tadeusz Robak. (2019) Moxetumomab pasudotox for the treatment of hairy cell leukemia. Expert Opinion on Biological Therapy 19:6, pages 501-508.
Read now
Read now
Articles from other publishers (26)
Kata Ferenczi, Zsófia Flóra Nagy, Ildikó Istenes, Hanna Eid, Csaba Bödör, Botond Timár & Judit Demeter. (2023) Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University. Pathology and Oncology Research 29.
Crossref
Crossref
Ernesto Gargiulo, Mirta Giordano, Carsten U. Niemann, Etienne Moussay, Jérôme Paggetti & Pablo Elías Morande. (2023) The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives. Frontiers in Oncology 13.
Crossref
Crossref
Elsa Maitre, Jerome Paillassa & Xavier Troussard. (2022) Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders. Frontiers in Oncology 12.
Crossref
Crossref
Tadeusz Robak & Paweł Robak. (2022) Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance. Frontiers in Oncology 12.
Crossref
Crossref
Jérôme Paillassa, Elsa Maitre & Xavier Troussard. (2022) Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances. Current Oncology Reports 24:9, pages 1133-1143.
Crossref
Crossref
Jan-Paul Bohn, Sabrina Neururer, Markus Pirklbauer, Andreas Pircher & Dominik Wolf. (2022) Hairy Cell Leukemia Patients Have a Normal Life Expectancy—A 35-Year Single-Center Experience and Comparison with the General Population. Cancers 14:5, pages 1242.
Crossref
Crossref
Elsa Maitre, Edouard Cornet, Véronique Salaün, Pauline Kerneves, Stéphane Chèze, Yohan Repesse, Gandhi Damaj & Xavier Troussard. (2022) Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders. Cancers 14:4, pages 1050.
Crossref
Crossref
Xavier Troussard, Elsa Maître & Edouard Cornet. (2021) Hairy cell leukemia 2022: Update on diagnosis, risk‐stratification, and treatment. American Journal of Hematology 97:2, pages 226-236.
Crossref
Crossref
Elsa Maitre & Xavier Troussard. (2022) Hairy Cell Leukemia and HCL-Like Disorders: Diagnosis and TreatmentLeuc閙ie �Tricholeucocytes et Autres Prolif閞ations �Cellules Chevelues: Diagnostic et Traitement. Oncologie 24:1, pages 3-24.
Crossref
Crossref
Robert J. Kreitman & Evgeny Arons. (2022) Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Reviews 51, pages 100888.
Crossref
Crossref
Julie Tran, Charles Gaulin & Martin S. Tallman. (2022) Advances in the Treatment of Hairy Cell Leukemia Variant. Current Treatment Options in Oncology 23:1, pages 99-116.
Crossref
Crossref
Anna Puła & Tadeusz Robak. (2021) Hairy cell leukemia: a brief update on current knowledge and treatment prospects. Current Opinion in Oncology 33:5, pages 412-419.
Crossref
Crossref
Jan-Paul Bohn, Stefan Salcher, Andreas Pircher, Gerold Untergasser & Dominik Wolf. (2021) The Biology of Classic Hairy Cell Leukemia. International Journal of Molecular Sciences 22:15, pages 7780.
Crossref
Crossref
Amany R. Keruakous, Pragathi Balakrishna, Sarah A. Schmidt, Marcus T. Autry & Adam Asch. (2021) Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant. Annals of Hematology 100:6, pages 1629-1630.
Crossref
Crossref
Rikhia Chakraborty, Omar Abdel-Wahab & Benjamin H. Durham. (2021) MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. Cold Spring Harbor Perspectives in Medicine 11:5, pages a034892.
Crossref
Crossref
Tadeusz Robak & Sascha Dietrich. 2021. Indolent Lymphomas. Indolent Lymphomas
179
194
.
Nilima Parry‐Jones, Anurag Joshi, Francesco Forconi & Claire Dearden. (2020) Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V). British Journal of Haematology 191:5, pages 730-737.
Crossref
Crossref
Andrea Visentin, Silvia Imbergamo, Valentina Trimarco, Stefano Pravato, Leila Romano Gargarella, Federica Frezzato, Greta Scapinello, Roberta Bertorelle, Elisa Piva, Monica Facco, Gianpietro Semenzato, Francesco Piazza & Livio Trentin. (2020) Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature. Hematological Oncology 38:5, pages 823-826.
Crossref
Crossref
Matthew Cross & Claire Dearden. (2020) Hairy Cell Leukaemia. Current Oncology Reports 22:5.
Crossref
Crossref
Robert J. Kreitman & Ira Pastan. (2020) Contextualizing the Use of Moxetumomab Pasudotox in the Treatment of Relapsed or Refractory Hairy Cell Leukemia. The Oncologist 25:1, pages e170-e177.
Crossref
Crossref
Mark B. Geyer, Omar Abdel-Wahab, Martin S. Tallman & Jae H. Park. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1872
1883.e5
.
Elsa Maitre, Edouard Cornet & Xavier Troussard. (2019) Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment. American Journal of Hematology 94:12, pages 1413-1422.
Crossref
Crossref
Paul Letendre & Donald Doll. (2018) Novel therapeutics in the treatment of hairy cell leukemia variant. Leukemia Research 75, pages 58-60.
Crossref
Crossref
Preetesh Jain, Rashmi Kanagal-Shamanna, Sergej Konoplev, Zhuang Zuo & Zeev Estrov. (2018)
Biclonal
IGHV
-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclax
. American Journal of Hematology 93:12, pages 1568-1569.
Crossref
Crossref
Andrea Visentin, Silvia Imbergamo, Federica Frezzato, Marco Pizzi, Roberta Bertorelle, Edoardo Scomazzon, Tamara Berno, Marcello Riva, Elisa Piva, Monica Facco, Francesco Piazza, Gianpietro Semenzato & Livio Trentin. (2017) Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases. Oncotarget 8:66, pages 110727-110731.
Crossref
Crossref
Xavier Troussard & Edouard Cornet. (2017) Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment. American Journal of Hematology 92:12, pages 1382-1390.
Crossref
Crossref